| abstract |
The present invention provides an antiviral agent having high antiviral activity against a drug-resistant virus that has acquired resistance to known antiviral agents (oseltamivir, amantadine, ganciclovir, etc.) and low side effects (cytotoxicity). Tricine [5,7,4′-trihydroxy-3 ′, 5′-dimethoxyflavone (tricin)] is used as an active ingredient. Antiviral agent against resistant virus. The resistant virus is preferably an influenza virus, a cytomegalovirus, or a herpes virus. [Selection figure] None |